Trump leverages tariff threats to secure deal with AstraZeneca on drug prices. Other firms in talks.

The president, along with key health officials, have admitted to utilizing tariff threats as a means to reach a deal. While some companies have agreed to terms, numerous others are currently engaged in discussions with the White House.